Observation on the Efficacy of Self-formulated Huatan Chushi Zhuyu Decoction in the Treatment of Adenoid Hypertrophy in Children and Literature Research on Traditional Chinese Medicine Treatment

Authors

  • Ying Wang Changping District Integrated Traditional Chinese and Western Medicine Hospital Author
  • Changwen Che Dongzhimen Hospital, Beijing University of Chinese Medicine Author
  • Mingsheng Zhang Dongzhimen Hospital, Beijing University of Chinese Medicine Author
  • Zhonghai Xin Wangjing Hospital, China Academy of Chinese Medical Sciences Author

DOI:

https://doi.org/10.71204/cp3e9n39

Keywords:

Adenoid Hypertrophy, Allergic Rhinitis, Decoction

Abstract

To observe the clinical efficacy of the self-formulated Huatan Chushi Zhuyu Decoction (HCZ Decoction) combined with basic Western medical treatment in children with moderate to severe adenoid hypertrophy (AH) accompanied by allergic rhinitis (AR), and to explore the theoretical basis by referring to traditional Chinese medicine (TCM) literature. A retrospective analysis was conducted. A total of 64 children with moderate to severe AH admitted to the outpatient department from January 2022 to December 2024 were included and divided into the decoction group (43 cases) and the non-decoction group (41 cases) according to the treatment regimen. The non-decoction group was treated with mometasone furoate nasal spray (100 μg/d) + montelukast (4-5 mg/d) for 2 weeks, combined with cetirizine (5-10 mg/d) for anti-allergy. On this basis, the decoction group was additionally given the HCZ Decoction (including tangerine peel, Poria cocos, Pinellia ternata, licorice, Arisaema cum Bile, peach kernel, Spina Gleditsiae, etc.), one dose per day, taken after breakfast and dinner, with a treatment course of 2 weeks. Baseline data such as age, gender, and BMI of the children in the two groups were collected. The differences in nasal symptom scale, pediatric sleep disorder scale, polysomnography (PSG) parameters, and the degree of AH before and after treatment were compared. The t-test and chi-square test were performed using SPSS 27.0 statistical software, with a significance level of P < 0.05. Chinese databases such as CNKI and Wanfang (from 2014 to 2024) were systematically searched. Using the Citespace 6.3 literature processing tool, the hotspots and clustering information of keywords, institutions, and co-authors related to the TCM treatment of AH in Chinese literature were analyzed. There were no statistical differences in general data and clinical baseline data between the two groups (P > 0.05), indicating comparability. The scores of various items in both the decoction group and the non-decoction group decreased after treatment, confirming the effectiveness of the treatment. The total score of OSA-18 was at the moderate to severe level, and there were differences in the total score and the changes of various scores between the decoction group and the non-decoction group, with the scores of the decoction group being lower. There was a difference in the change score of the total nasal symptom score (TNSS) between the two groups, mainly manifested in nasal obstruction and sneezing. There were no differences in the changes of OAHI and LSaO2 scores between the two groups. The literature study showed that the core therapeutic methods of TCM treatment for AH are "resolving phlegm, removing dampness, and promoting blood circulation to remove blood stasis", which highly coincides with the compatibility of the self-formulated decoction. The HCZ Decoction combined with basic Western medical treatment can significantly improve the nasal symptoms and sleep quality of children with moderate to severe AH accompanied by AR. Its curative effect may be achieved by regulating the local inflammatory response rather than reducing the volume of the adenoids. TCM literature supports that ‘the intermingling of phlegm, blood stasis, and dampness’ is the core pathogenesis of AH. This decoction provides a safe and effective non-surgical treatment option for clinical practice.

References

Ahmad, Z., Krüger, K., Lautermann, J., Lippert, B., Tenenbaum, T., Tigges, M., Tisch, M. (2023). Adenoid hypertrophy-diagnosis and treatment: the new S2k guideline. HNO, 71(Suppl 1), 67-72.

Alimoglu, Y., Altin, F., Yorguner, N. E., Acikalin, R. M., & Yasar, H. (2020). Predicting the outcome after adenoidectomy-alone for adenoid hypertrophy causing sleep disordered breathing. American Journal of Otolaryngology, 41(6), 102646.

Cheng, M., Dai, Q., Liu, Z., Wang, Y., Zhou, C. (2024). New progress in pediatric allergic rhinitis. Front Immunol, 15, 1452410.

Diksha, Singhal, S. K., Gupta, N., Gupta, R., & Verma, R. R. (2022). Radiological and audiological assessment in patients with adenoid hypertrophy undergoing adenoidectomy. Indian Journal of Otolaryngology and Head & Neck Surgery, 74(Suppl 2), 1527-1531.

Eldegeir, M., Marry, N. A., Awami, F., Alsada, F. (2023). The combination of nasal steroids and anti-leukotriene to reduce adenectomy in children with OSA and adenoid hypertrophy. Qatar Med J, (2), 31.

Joseph, M., Krishna, M. M., Franco, A. J., Jekov, L., Sudo, R. Y. U., & Cabral, T. D. D. (2025). Efficacy of combination therapy with mometasone and montelukast versus mometasone alone in treatment of adenoid hypertrophy in children: A systematic review and meta-analysis. American Journal of Otolaryngology, 46(1), 104566.

Lee, D. J., Chung, Y. J., Yang, Y. J., & Mo, J. H. (2018). The impact of allergic rhinitis on symptom improvement in pediatric patients after adenotonsillectomy. Clinical and Experimental Otorhinolaryngology, 11(1), 52-57.

Niedzielski, A., Chmielik, L. P., Mielnik-Niedzielska, G., Kasprzyk, A., Bogusławska, J. (2023). Adenoid hypertrophy in children: a narrative review of pathogenesis and clinical relevance. BMJ Paediatr Open, 7(1), e001710.

Pavon-Romero, G. F., Larenas-Linnemann, D. E., Xochipa Ruiz, K. E., Ramirez-Jimenez, F., & Teran, L. M. (2021). Subcutaneous allergen-specific immunotherapy is safe in pediatric patients with allergic rhinitis. International Archives of Allergy and Immunology, 182(6), 553-561.

Randall, D. A. (2020). Current Indications for Tonsillectomy and Adenoidectomy. J Am Board Fam Med, 33(6), 1025-1030

Schupper, A. J., Nation, J., Pransky, S., et al. (2018). Adenoidectomy in Children: What Is the Evidence and What Is its Role?. Curr Otorhinolaryngol Rep, 6, 64–73.

Shivnani, D., Kobal, M. R., Raman, E. V., Shruthi, M. S. (2023). Impact of Chronic Adenoid Hypertrophy on Quality of Life Index in Children and Role of Adenoidectomy. Indian J Otolaryngol Head Neck Surg, 75(4), 3396-3401.

Sun, Y. L., Zheng, H. T., Tao, J. L., Jiang, M. C., Hu, C. C., Li, X. M., & Yuan, B. (2019). Effectiveness and safety of Chinese herbal medicine for pediatric adenoid hypertrophy: A meta-analysis. International Journal of Pediatric Otorhinolaryngology, 119, 79-85.

Tse, K. L., Savoldi, F., Li, K. Y., McGrath, C. P., Yang, Y., Gu, M. (2023). Prevalence of adenoid hypertrophy among 12-year-old children and its association with craniofacial characteristics: a cross-sectional study. Prog Orthod, 24(1), 31.

Varghese, A. M., Naina, P., Cheng, A. T., Asif, S. K., & Kurien, M. (2016). ACE grading—A proposed endoscopic grading system for adenoids and its clinical correlation. International Journal of Pediatric Otorhinolaryngology, 83, 155-159.

Velentza, L., Maridaki, Z., Blana, E., & Miligkos, M. (2020). Antihistamines in the management of pediatric allergic rhinitis: A systematic review. Paediatric Drugs, 22(6), 673-683.

Zhang, J., Fu, Y., Wang, L., Wu, G. (2024). Adenoid facies: a long-term vicious cycle of mouth breathing, adenoid hypertrophy, and atypical craniofacial development. Front Public Health, 12, 1494517.

Zhang, M., Fan, Y., Tian, C., Xie, Y., Huang, Y., Yang, S., & Zhang, Q. (2020). The efficacy and safety of Chinese herbal compound in pediatric patients with allergic rhinitis: A protocol for systematic review and meta-analysis. Medicine, 99(32), e21643.

Zhao, X., Xu, J., Wang, M. Y., Hou, Z. W., Shi, H. S., & Zhang, X. X. (2023). Effect of oral Xiao-xian decoction combined with acupoint application therapy on pediatric adenoid hypertrophy: A randomized trial. Medicine, 102(5), e32804.

Zwierz, A., Domagalski, K., Masna, K., Burduk, P. (2024). Maximal medical treatment of adenoid hypertrophy: a prospective study of preschool children. Eur Arch Otorhinolaryngol, 281(5), 2477-2487.

Downloads

Published

2025-06-12

Data Availability Statement

Not applicable

How to Cite

Observation on the Efficacy of Self-formulated Huatan Chushi Zhuyu Decoction in the Treatment of Adenoid Hypertrophy in Children and Literature Research on Traditional Chinese Medicine Treatment. (2025). Advances in World Medical Research, 1(1), 34-49. https://doi.org/10.71204/cp3e9n39